Company Overview and News

Tidal Royalty Corp. Completes $30MM Equity Financing & Announces Listing on the Canadian Securities Exchange

2018-06-21 globenewswire
TORONTO, June 21, 2018 (GLOBE NEWSWIRE) -- Tidal Royalty Corp. (“Tidal Royalty” or the “Company”), a leading provider of royalty financing to licensed US cannabis operators, is pleased to announce that it will commence trading on the Canadian Securities Exchange under the ticker “RLTY” on Monday, June 25, 2018.

PRMCF / Pharmacan Capital Corp. - Stock Institutional Ownership and Shareholders -

Pharmacan Capital Corp. (OTC:PRMCF) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,029,066 shares. Largest shareholders include Gotham Green Fund 1, L.p., and Vantage Investment Advisors, LLC. Pharmacan Capital Corp. (OTC:PRMCF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.

Namaste Technologies - Vaporizing Shareholder Value (80% Downside)

2018-05-04 seekingalpha
Management has a well-documented history of failure coupled with repeated misses on their financial/operational targets; CEO used to be in the knock-off purse business.

Buzz Capital Inc. Enters into Binding Letter of Intent for Proposed Qualifying Transaction

2018-03-16 globenewswire
OTTAWA, March 16, 2018 (GLOBE NEWSWIRE) -- Buzz Capital Inc. (the “Corporation” or “Buzz”) (TSX-V:BUZ.P) is pleased to announce it has entered into a letter of intent dated March 15, 2018 (the “Letter of Intent”) with Kaya Inc. (“Kaya”) pursuant to which Buzz has agreed to acquire all of the outstanding securities of Kaya, a vertically integrated cannabis company licensed to cultivate, process, distribute, and retail medical cannabis in Jamaica (through its affiliate Island Kaya), which, subject to certain conditions and applicable shareholder, corporate and TSX Venture Exchange (the “Exchange”) approvals will constitute the Corporation’s “Qualifying Transaction” as such term is defined under the policies of the Exchange.

Related Articles

HIMX: Himax Technologies Analysis and Research Report

2018-06-24 - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Silicon Investor Message Boards

This table lists all message boards related to TSXV:MJN / Pharmacan Capital Corp on message board site Silicon Investor.

Medical Marijuana (MJNA)